Business
Press Release Jul 21 2023
Lupin Limited has informed the Exchange regarding a press release dated July 21, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated July 21, 2023, titled \"Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets\". View Attachment","length":374,"tagName":"div"}]